SCHEMBL17525283

SCHEMBL17525283

CC(=O)N1c2ccccc2C(C)(C)c2ccc(Nc3ccccc3C)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 2/20 0.44
▸ MAPK13 O15264 3/20 0.42
▸ MAPK12 P53778 3/20 0.42
▸ MAPK11 Q15759 3/20 0.42
▸ MAPK14 Q16539 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NOTUM Q6P988 1/20 0.37
▸ BCHE P06276 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK10 P53779 1/20 0.35
▸ NOX1 Q9Y5S8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17522829 0.79 ACVRL1 (0.40) MAPK13MAPK12MAPK11MAPK14KDM4E
SCHEMBL17525276 0.77 SMN1; SMN2 (0.58) KDM4EALDH1A1L3MBTL1SMN1; SMN2GAA
SCHEMBL17525288 0.74 KDM4E (0.45) TP53KDM4EALDH1A1L3MBTL1POLB
SCHEMBL18287259 0.74 GAA (0.40) TP53MAPK13MAPK12MAPK11MAPK14
SCHEMBL28518676 0.72 MAPK14 (0.41) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL19844386 0.70 MAPK14 (0.41) TP53MAPK13MAPK12MAPK11MAPK14
SCHEMBL17522830 0.67 P2RX4 (0.42) TP53KDM4EALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL1572546 0.67 HSD17B10 (0.60) TP53ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL13828515 0.67 MAPT (0.53) MAPK13MAPK12MAPK11MAPK14KDM4E
SCHEMBL27718637 0.67 MAPK13 (0.59) MAPK13MAPK12MAPK11MAPK14ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE AHR, CDYL, SLC18A1 TP53 3167/4885MAPK13 2155/4885MAPK12 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback